Furthermore, ERK2 suppression dramatically suppressed the migration and invasion of MDA-MB-231 and MCF-7 cells (Figures S4F and S4G), indicating that ERK2 contributed to the tumorigenesis of breast cancer. The gene discussed is MAPK1; the disease is breast carcinoma.